OMHE

Omni Health, Inc. OMHE

OMHE
Omni Health, Inc. NVOS
Novo Integrated Sciences, Inc. ADVT
Advantis Corp. BBBT
Black Bird Biotech, Inc. PBLA
Panbela Therapeutics, Inc. ACGI
The Amacore Group, Inc. LGND
Ligand Pharmaceuticals Incorporated ARMM
Armm Inc. SONX
Sonendo, Inc. EHOS
Ehouse Global, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode OMHE NVOS ADVT BBBT PBLA ACGI LGND ARMM SONX EHOS
6M 200.00 % 25.00 % 0.00 % 0.00 % -99.87 % 0.00 % 76.27 % 0.00 % -78.26 % 0.00 %
YTD 200.00 % -95.04 % 0.00 % 0.00 % -99.93 % 0.00 % 85.45 % 0.00 % -86.34 % 900.00 %
1Y 200.00 % -92.75 % 0.00 % 0.00 % -99.91 % 0.00 % 76.69 % 0.00 % -86.49 % 900.00 %
3Y -40.00 % -99.87 % -90.00 % -88.89 % -100.00 % -90.00 % 199.97 % -99.82 % -99.92 % -90.00 %
5Y -85.00 % -99.94 % -97.50 % -99.79 % -100.00 % -98.33 % 94.87 % -99.98 % -99.99 % 49 900.00 %
10Y -99.57 % -99.94 % -99.83 % -97.56 % -100.00 % -97.50 % 87.34 % -99.98 % -99.99 % 9 999 900.00 %
From the beginning 50.00 % -99.94 % -100.00 % -99.99 % -100.00 % -100.00 % 338.52 % -99.98 % -99.99 % -66.67 %

Dividend

Ligand Pharmaceuticals Incorporated